Kodiak Sciences Inc.
KOD stock score: 49/100
$87.72 · -5.65% · Scored Oct 21, 2026
- Technical
- 70
- Fundamental
- 29
- News
- 52
The reading
Kodiak Sciences (KOD) scores 49 out of 100, which reads weak, higher than 60% of Healthcare stocks and 40% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 70, fundamentals 29.
Among the fundamentals, Price Target at 100 and Fund Ownership at 100 score highest, while Earnings Growth (5-Year) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 73 and contrarian oscillators 40 — a split worth reading before trusting the technical total.
News sentiment is neutral at 52; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 40 to 57, and it is down 7 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward KOD’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
29Pulling it up
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Fund Ownership100
Fund ownership tracks institutional investor holdings and changes.
- Institutional Ownership100
Institutional ownership measures the percentage held by professional investors.
Holding it back
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
- Price to Book Ratio0
Price-to-Book ratio compares market value to book value.
- Return on Equity (ROE)0
Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.
27 weighted scorers; 14 had no data today and are left out rather than counted as zero.
Technical · daily
69Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- EMA 50100
Exponential Moving Average (50-period) is a key intermediate-term trend indicator that responds more quickly than SMA-50.
- SMA 50100
Simple Moving Average (50-period) is a widely-watched intermediate-term trend gauge.
Holding it back
- Stock Volatility1
Stock volatility measures price fluctuation magnitude over time.
- MACD (12)15
Moving Average Convergence Divergence tracks the relationship between two exponential moving averages.
- RSI (50)16
Relative Strength Index (50-period) provides a longer-term view of momentum compared to RSI-14.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 52
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 37 | 1 |
| Daily | 69 | 3 |
| Weekly | 72 | 2 |
| Monthly | 76 | 2 |
| Quarterly | 78 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 21, 2026 | 49 |
| Oct 20, 2026 | 51 |
| Oct 19, 2026 | 51 |
| Oct 18, 2026 | 49 |
| Oct 17, 2026 | 49 |
| Oct 16, 2026 | 49 |
| Oct 15, 2026 | 49 |
| Oct 14, 2026 | 48 |
| Oct 13, 2026 | 50 |
| Oct 12, 2026 | 52 |
| Oct 11, 2026 | 52 |
| Oct 10, 2026 | 52 |
| Oct 9, 2026 | 52 |
| Oct 8, 2026 | 52 |
| Oct 7, 2026 | 50 |
| Oct 6, 2026 | 51 |
| Oct 5, 2026 | 51 |
| Oct 4, 2026 | 51 |
| Oct 3, 2026 | 51 |
| Oct 2, 2026 | 51 |
| Oct 1, 2026 | 50 |
| Sep 30, 2026 | 51 |
| Sep 29, 2026 | 51 |
| Sep 28, 2026 | 50 |
| Sep 27, 2026 | 43 |
| Sep 26, 2026 | 43 |
| Sep 25, 2026 | 43 |
| Sep 24, 2026 | 43 |
| Sep 23, 2026 | 41 |
| Sep 22, 2026 | 43 |
| Sep 21, 2026 | 42 |
| Sep 20, 2026 | 41 |
| Sep 19, 2026 | 41 |
| Sep 18, 2026 | 41 |
| Sep 17, 2026 | 42 |
| Sep 16, 2026 | 41 |
| Sep 15, 2026 | 41 |
| Sep 14, 2026 | 42 |
| Sep 13, 2026 | 42 |
| Sep 12, 2026 | 42 |
| Sep 11, 2026 | 40 |
| Sep 10, 2026 | 40 |
| Sep 9, 2026 | 41 |
| Sep 8, 2026 | 43 |
| Sep 7, 2026 | 42 |
| Sep 6, 2026 | 42 |
| Sep 5, 2026 | 42 |
| Sep 4, 2026 | 41 |
| Sep 3, 2026 | 42 |
| Sep 2, 2026 | 45 |
| Sep 1, 2026 | 44 |
| Aug 31, 2026 | 43 |
| Aug 30, 2026 | 43 |
| Aug 29, 2026 | 43 |
| Aug 28, 2026 | 43 |
| Aug 27, 2026 | 47 |
| Aug 26, 2026 | 45 |
| Aug 25, 2026 | 45 |
| Aug 24, 2026 | 42 |
| Aug 23, 2026 | 44 |
| Aug 22, 2026 | 44 |
| Aug 20, 2026 | 51 |
| Aug 19, 2026 | 51 |
| Aug 18, 2026 | 51 |
| Aug 17, 2026 | 51 |
| Aug 16, 2026 | 49 |
| Aug 15, 2026 | 49 |
| Aug 14, 2026 | 49 |
| Aug 13, 2026 | 50 |
| Aug 12, 2026 | 53 |
| Aug 11, 2026 | 51 |
| Aug 10, 2026 | 52 |
| Aug 9, 2026 | 53 |
| Aug 8, 2026 | 53 |
| Aug 7, 2026 | 53 |
| Aug 6, 2026 | 53 |
| Aug 5, 2026 | 53 |
| Aug 3, 2026 | 51 |
| Aug 2, 2026 | 53 |
| Jul 31, 2026 | 56 |
| Jul 30, 2026 | 56 |
| Jul 29, 2026 | 54 |
| Jul 28, 2026 | 54 |
| Jul 27, 2026 | 57 |
| Jul 26, 2026 | 56 |
| Jul 25, 2026 | 56 |
Key facts
- Market cap
- $5.5B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 2.04
- Risk grade (1–10)
- 9
- Next earnings
- Nov 12, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| CGON CG Oncology | $5.5B | 47 |
| COGT Cogent Biosciences | $5.5B | 47 |
| MIRM Mirum Pharmaceuticals | $5.4B | 49 |
| ORKA Oruka Therapeutics | $5.3B | 42 |
| SRRK Scholar Rock Holding | $5.2B | 45 |
| PTCT PTC Therapeutics | $5.2B | 63 |
Questions
What is KOD's stock score today?
KOD scores 49/100 (Weak) as of Oct 21, 2026: technical 70, fundamental 29, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.
Is KOD a buy?
The score is not a buy or sell recommendation. A 49 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the KOD score calculated?
88 weighted scorers feed it today: 27 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.